AbbVie Inc ABBV:NYSE
RT Quote | Last NASDAQ LS, VOL From CTA | USD
After Hours: Last | 5:34 PM EDT218.20
+1.07 (+0.49%)
+1.07 (+0.49%)Volume
314,575
Close
217.13+1.73 (+0.80%)
+1.73 (+0.80%)Volume
5,330,350
52 week range
181.73 - 244.81
- Open214.80
- Day High219.54
- Day Low213.73
- Prev Close215.40
- 52 Week High244.81
- 52 Week High Date10/01/25
- 52 Week Low181.73
- 52 Week Low Date06/27/25
Latest On AbbVie Inc
Key Stats
- Market Cap383.624B
- Shares Out1.77B
- 10 Day Average Volume5.45M
- Dividend6.92
- Dividend Yield3.19%
- Beta0.31
Latest On AbbVie Inc
KEY STATS
- Open214.80
- Day High219.54
- Day Low213.73
- Prev Close215.40
- 52 Week High244.81
- 52 Week High Date10/01/25
- 52 Week Low181.73
- 52 Week Low Date06/27/25
- Market Cap383.624B
- Shares Out1.77B
- 10 Day Average Volume5.45M
- Dividend6.92
- Dividend Yield3.19%
- Beta0.31
RATIOS/PROFITABILITY
- EPS (TTM)2.03
- P/E (TTM)107.16
- Fwd P/E (NTM)14.56
- EBITDA (TTM)30.073B
- ROE (TTM)15,221.82%
- Revenue (TTM)62.819B
- Gross Margin (TTM)72.03%
- Net Margin (TTM)5.80%
- Debt To Equity (MRQ)-1,094.62%
EVENTS
- Earnings Date07/29/2026(est)
- Ex Div Date04/15/2026
- Div Amount1.73
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MOREAbbVie Inc. is a global, diversified, research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. The aesthetics...
Robert Michael CPA
Chairman of the Board, Chief Executive Officer
Azita Saleki-Gerhardt Ph.D.
Executive Vice President, Chief Operations Officer
Scott Reents
Chief Financial Officer, Executive Vice President
Perry Siatis
Executive Vice President, General Counsel, Secretary
Nicholas Donoghoe M.D.
Executive Vice President, Chief Business and Strategy Officer
Address
1 N Waukegan Rd
North Chicago, IL
60064
United States